Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
New Clinical Data Shows Abiomed Impella RP Heart Pump is Safe, Despite Concerns Over Patient Deaths: FDA FDA says Abiomed Impella RP Heart Pump Systems are safe enough to use, but must be limited to specific patient populations. December 6, 2022 Russell Maas Add Your Comments Although federal health officials have expressed concerns about increased Abiomed Impella RP Heart Pump Systems mortality rates , the FDA now indicates the medical device is safe for use in patients meeting certain medical criteria. The Abiomed Impella RP Heart Pump System is used as an emergency implant to improve right ventricular function of the heart. The implant is designed to pump blood from the vena cava through the heart and into the pulmonary arteries which lead to the lungs. It is often used for 14 days while patients are in the hospital awaiting treatment for heart transplant or implantation of a surgical right ventricular assist device (RVAD). The FDA issued premarket approval of the Abiomed Impella RP Heart Pump System in September 2017, requiring the manufacturer to conduct a post-approval study (PAS) as a condition of approval for the Impella RP System, with the same primary endpoint as the premarket clinical studies. However, interim results of the PAS released in 2019 found the devices were being used in a broader range of patient populations than previously restricted in the initial clinical trials. The findings further revealed an increased risk of death was associated with individuals receiving Impella RP Heart Pumps that did not meet the clinical trials patient criteria. As a result, the FDA issued a Abiomed Impella RP Heart Pump System warning on May 21, 2019, alerting healthcare professionals of an increased rate of mortality associated with the use of the devices. Officials warned healthcare providers that if a patient would not have qualified for the clinical trials initially used to gain FDA approval, then they likely face an increased risk of death after being implanted with the heart pumps. While early clinical trials of strictly qualifying patients showed a 73% survival rate, the interim results released in 2019 from real-world use identified only 28% of patients survived to the start of the next long-term therapy. Abiomed Impella RP Heart Pump Label Update Following the completion of the post-approval study, officials released an Approval Study Results and Updated Labeling communication to healthcare professionals on December 5, which warns against using the Abiomed Impella RP Heart Pump System in non-specified patient populations. Impella Heart Pump Lawsuit Did you suffer injuries from an Impella Heart Pump? Lawyers are reviewing Impella Heart Pump lawsuits for individuals who suffered injuries or were fatally injured by a heart pump perforation. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Impella Heart Pump Lawsuit Did you suffer injuries from an Impella Heart Pump? Lawyers are reviewing Impella Heart Pump lawsuits for individuals who suffered injuries or were fatally injured by a heart pump perforation. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to the notice, the updated labeling will now require the following usage guidelines for the device; “The Impella RP System is indicated for providing temporary right ventricular support for up to 14 days in patients with a body surface area ≥1.5 m2, who develop acute right heart failure or decompensation for less than 48 hours following left ventricular assist device implantation, myocardial infarction, heart transplant, or open‐heart surgery, without the presence of profound shock, end organ failure, or acute neurologic injury.” The new labeling now specifies the heart pump implants are to only be used in patients who have not experienced shock, organ failure or acute neurologic injury in conjunction with right-side heart failure. The agency is instructing health care providers to read and follow the updated label-usage updates for the Impella RP System and to thoroughly discuss the benefits and risks of the devices with patients and their caregivers when making treatment decisions. Any and all adverse events involving the Impella RP System should be reported to the agency to help the FDA identify and better understand the risks associated with medical devices. Tags: Abiomed, Clinical Trials, Heart Failure, Heart Pump More Impella Heart Pump Lawsuit Stories Impella Recall Issued Over Guidewire Problems in RP Heart Pump With SmartAssist February 17, 2025 Updated Impella Lawsuit Submitted Over Death Linked to Pump Used During Cardiac Surgery February 7, 2025 Abiomed Impella Lawsuit Alleges Heart Pump Caused Wrongful Death of Illinois Woman January 15, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES 6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: today) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025) MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
Updated Impella Lawsuit Submitted Over Death Linked to Pump Used During Cardiac Surgery February 7, 2025
6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: today) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)